The risk or severity of adverse effects can be increased when phenobarbital is combined with Butethal.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when quinapril is combined with niflumic acid.


The risk or severity of adverse effects can be increased when propranolol is combined with D-mannitol.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with benzocaine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Normethadone.


The risk or severity of adverse effects can be increased when phenobarbital is combined with amobarbital.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with vigabatrin.


The risk or severity of adverse effects can be increased when prazosin is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Tapentadol is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when alclofenac is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with nortriptyline.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with amoxapine.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Escitalopram.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with moclobemide.


The risk or severity of adverse effects can be increased when zaleplon is combined with gabapentin.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when metaraminol is combined with dopamine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with bicalutamide.


The risk or severity of adverse effects can be increased when ethopropazine is combined with topiramate.


The risk or severity of adverse effects can be increased when dyclonine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when ketamine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Remoxipride.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when estazolam is combined with trazodone.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with protriptyline.


The risk or severity of adverse effects can be increased when diazepam is combined with trimipramine.


The risk or severity of adverse effects can be increased when diazepam is combined with procaine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when ramipril is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when dapsone is combined with flutamide.


The risk or severity of adverse effects can be increased when Salsalate is combined with triamcinolone.


The risk or severity of adverse effects can be increased when carisoprodol is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with tretinoin.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with felbamate.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with glutethimide.


The risk or severity of adverse effects can be increased when loratadine is combined with doxepin.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with fexofenadine.


The risk or severity of adverse effects can be increased when oxazepam is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when hydralazine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Carbetocin is combined with sevoflurane.


The risk or severity of adverse effects can be increased when propofol is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when pentazocine is combined with indapamide.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with manidipine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with potassium ion.


The risk or severity of adverse effects can be increased when pentazocine is combined with Halazepam.


The risk or severity of adverse effects can be increased when apomorphine is combined with hydralazine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with flumethasone.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Asenapine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with tizanidine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with furosemide.


The risk or severity of adverse effects can be increased when alclofenac is combined with diflorasone.


The risk or severity of adverse effects can be increased when Dothiepin is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when halothane is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when halothane is combined with tolazoline.


The risk or severity of adverse effects can be increased when halothane is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when bromazepam is combined with dibucaine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Asenapine.


The risk or severity of adverse effects can be increased when topiramate is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when pentobarbital is combined with butorphanol.


The risk or severity of adverse effects can be increased when pramipexole is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when gabapentin is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Retigabine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when benazepril is combined with tenoxicam.


The risk or severity of adverse effects can be increased when diltiazem is combined with papaverine.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when celecoxib is combined with flunisolide.


The risk or severity of adverse effects can be increased when benazepril is combined with nabumetone.


The risk or severity of adverse effects can be increased when Temsirolimus is combined with clozapine.


The risk or severity of adverse effects can be increased when benazepril is combined with ketorolac.


The risk or severity of adverse effects can be increased when isradipine is combined with hydralazine.


The risk or severity of adverse effects can be increased when captopril is combined with antipyrine.


The risk or severity of adverse effects can be increased when benazepril is combined with niflumic acid.


The risk or severity of adverse effects can be increased when halothane is combined with triprolidine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when halothane is combined with spironolactone.


The risk or severity of adverse effects can be increased when halothane is combined with methocarbamol.


The risk or severity of adverse effects can be increased when antipyrine is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when nabumetone is combined with Naftifine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when buprenorphine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with prednisone.


The risk or severity of adverse effects can be increased when Aclidinium is combined with nalbuphine.


The risk or severity of adverse effects can be increased when methylene blue is combined with formoterol.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with loratadine.


The risk or severity of adverse effects can be increased when Miltefosine is combined with Benidipine.


The risk or severity of adverse effects can be increased when prazepam is combined with meclizine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when barnidipine is combined with Torasemide.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when benzocaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when benzocaine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when hydromorphone is combined with dibucaine.


The risk or severity of adverse effects can be increased when naratriptan is combined with MELPERONE.


The risk or severity of adverse effects can be increased when antipyrine is combined with Propacetamol.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Artemether is combined with nifedipine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with flunisolide.


The risk or severity of adverse effects can be increased when Rufinamide is combined with codeine.


The risk or severity of adverse effects can be increased when diazepam is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with bumetanide.


The risk or severity of adverse effects can be increased when Rufinamide is combined with pentobarbital.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with Tramadol.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with Efonidipine.


The risk or severity of adverse effects can be increased when vigabatrin is combined with nefazodone.


The risk or severity of adverse effects can be increased when midodrine is combined with terbutaline.


The risk or severity of adverse effects can be increased when celecoxib is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when trazodone is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with loratadine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with imipramine.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with orphenadrine.


The risk or severity of adverse effects can be increased when Efonidipine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when nitrendipine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when brotizolam is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when nitric oxide is combined with clonidine.


The risk or severity of adverse effects can be increased when levorphanol is combined with Flupentixol.


The risk or severity of adverse effects can be increased when meperidine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with clidinium.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Perospirone.


The risk or severity of adverse effects can be increased when triflupromazine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when levorphanol is combined with Conivaptan.


The risk or severity of adverse effects can be increased when meprobamate is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when prazosin is combined with apraclonidine.


The risk or severity of adverse effects can be increased when baclofen is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when sotalol is combined with benazepril.


The risk or severity of adverse effects can be increased when hexetidine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when amifostine is combined with Arotinolol.


The risk or severity of adverse effects can be increased when Rufinamide is combined with oxymorphone.


The risk or severity of adverse effects can be increased when clorazepate is combined with amitriptyline.


The risk or severity of adverse effects can be increased when EDTA is combined with Nintedanib.


The risk or severity of adverse effects can be increased when tacrolimus is combined with altretamine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with zopiclone.


The risk or severity of adverse effects can be increased when Etidocaine is combined with doxepin.


The risk or severity of adverse effects can be increased when gabapentin is combined with primidone.


The risk or severity of adverse effects can be increased when Naftifine is combined with resveratrol.


The risk or severity of adverse effects can be increased when Etidocaine is combined with nefazodone.


The risk or severity of adverse effects can be increased when etizolam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when amobarbital is combined with Normethadone.


The risk or severity of adverse effects can be increased when clozapine is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when tolmetin is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when tolmetin is combined with salicylic acid.


The risk or severity of adverse effects can be increased when lorazepam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when methadone is combined with Melatonin.


The risk or severity of adverse effects can be increased when betaxolol is combined with hydralazine.


The risk or severity of adverse effects can be increased when trazodone is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when morphine is combined with losartan.


The risk or severity of adverse effects can be increased when etizolam is combined with levodopa.


The risk or severity of adverse effects can be increased when tetracaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when mepivacaine is combined with HEROIN.


The risk or severity of adverse effects can be increased when bupivacaine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when methadone is combined with butalbital.


The risk or severity of adverse effects can be increased when procarbazine is combined with rasagiline.


The risk or severity of adverse effects can be increased when procarbazine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when Articaine is combined with doxepin.


The risk or severity of adverse effects can be increased when cabergoline is combined with irinotecan.


The risk or severity of adverse effects can be increased when cabergoline is combined with methimazole.


The risk or severity of adverse effects can be increased when trazodone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when furosemide is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when rizatriptan is combined with moclobemide.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with spironolactone.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Escitalopram.


The risk or severity of adverse effects can be increased when thiopental is combined with tetracaine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when zaleplon is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with oxazepam.


The risk or severity of adverse effects can be increased when dobutamine is combined with terbutaline.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with nalbuphine.


The risk or severity of adverse effects can be increased when benzocaine is combined with doxepin.


The risk or severity of adverse effects can be increased when LISURIDE is combined with vincristine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when benzocaine is combined with nefazodone.


The risk or severity of adverse effects can be increased when BOPINDOLOL is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with zafirlukast.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Pramocaine.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with memantine.


The risk or severity of adverse effects can be increased when selegiline is combined with losartan.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Bortezomib.


The risk or severity of adverse effects can be increased when nitrendipine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when clorazepate is combined with Normethadone.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when olanzapine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when olanzapine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when enflurane is combined with cetirizine.


The risk or severity of adverse effects can be increased when ticlopidine is combined with salicylic acid.


The risk or severity of adverse effects can be increased when Efonidipine is combined with pravastatin.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with triamcinolone.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with paroxetine.


The risk or severity of adverse effects can be increased when dexamethasone is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when topiramate is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when clorazepate is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when docetaxel is combined with Octreotide.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when quazepam is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when nimesulide is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when reserpine is combined with deslanoside.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with doxepin.


The risk or severity of adverse effects can be increased when nimesulide is combined with Halobetasol.


The risk or severity of adverse effects can be increased when chlormezanone is combined with clidinium.


The risk or severity of adverse effects can be increased when reserpine is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with nefazodone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with tetracaine.


The risk or severity of adverse effects can be increased when diltiazem is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when Articaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with enalapril.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with nilvadipine.


The risk or severity of adverse effects can be increased when Levomepromazine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Sacubitril.


The risk or severity of adverse effects can be increased when ethotoin is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when thioridazine is combined with ramipril.


The risk or severity of adverse effects can be increased when thioridazine is combined with valsartan.


The risk or severity of adverse effects can be increased when ambenonium is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when Asenapine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Asenapine is combined with Butethal.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with triamcinolone.


The risk or severity of adverse effects can be increased when morphine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when zopiclone is combined with tetracaine.


The risk or severity of adverse effects can be increased when Torasemide is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when methadone is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when aspirin is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when zaleplon is combined with Pramocaine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with ambenonium.


The risk or severity of adverse effects can be increased when propoxyphene is combined with prilocaine.


The risk or severity of adverse effects can be increased when selegiline is combined with pimozide.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when furazolidone is combined with Isometheptene.


The risk or severity of adverse effects can be increased when brimonidine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when zonisamide is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when cilnidipine is combined with timolol.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when trazodone is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with amoxapine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Apremilast is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with salicylamide.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with prazepam.


The risk or severity of adverse effects can be increased when oxprenolol is combined with tretinoin.


The risk or severity of adverse effects can be increased when oxprenolol is combined with ethotoin.


The risk or severity of adverse effects can be increased when docetaxel is combined with Axitinib.


The risk or severity of adverse effects can be increased when lovastatin is combined with oxycodone.


The risk or severity of adverse effects can be increased when Pipamperone is combined with phenytoin.


The risk or severity of adverse effects can be increased when haloperidol is combined with METAXALONE.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with enflurane.


The risk or severity of adverse effects can be increased when Pregabalin is combined with fluoxetine.


The risk or severity of adverse effects can be increased when cetirizine is combined with doxepin.


The risk or severity of adverse effects can be increased when Carbetocin is combined with nicardipine.


The risk or severity of adverse effects can be increased when pirenzepine is combined with Tramadol.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when butorphanol is combined with primidone.


The risk or severity of adverse effects can be increased when buspirone is combined with topiramate.


The risk or severity of adverse effects can be increased when Lurasidone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Lurasidone is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Lurasidone is combined with zotepine.


The risk or severity of adverse effects can be increased when pentazocine is combined with thiothixene.


The risk or severity of adverse effects can be increased when nimodipine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when dexamethasone is combined with enoxacin.


The risk or severity of adverse effects can be increased when methyldopa is combined with irbesartan.


The risk or severity of adverse effects can be increased when docetaxel is combined with Pixantrone.


The risk or severity of adverse effects can be increased when Olmesartan is combined with salicylamide.


The risk or severity of adverse effects can be increased when flurazepam is combined with Normethadone.


The risk or severity of adverse effects can be increased when Olsalazine is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when methyldopa is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when methyldopa is combined with felodipine.


The risk or severity of adverse effects can be increased when lidocaine is combined with brotizolam.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Olsalazine is combined with amcinonide.


The risk or severity of adverse effects can be increased when olanzapine is combined with trimipramine.


The risk or severity of adverse effects can be increased when methysergide is combined with roxithromycin.


The risk or severity of adverse effects can be increased when olanzapine is combined with procaine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when nitric oxide is combined with apraclonidine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Telmisartan.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with vigabatrin.


The risk or severity of adverse effects can be increased when methysergide is combined with etoposide.


The risk or severity of adverse effects can be increased when ATROPINE is combined with Pentolinium.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with clozapine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Eplerenone.


The risk or severity of adverse effects can be increased when cilnidipine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when labetalol is combined with nylidrin.


The risk or severity of adverse effects can be increased when butorphanol is combined with spironolactone.


The risk or severity of adverse effects can be increased when trazodone is combined with methocarbamol.


The risk or severity of adverse effects can be increased when butorphanol is combined with methocarbamol.


The risk or severity of adverse effects can be increased when mesalamine is combined with prednisone.


The risk or severity of adverse effects can be increased when trazodone is combined with triprolidine.


The risk or severity of adverse effects can be increased when butorphanol is combined with triprolidine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with niflumic acid.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Milnacipran.


The risk or severity of adverse effects can be increased when oxiconazole is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when terconazole is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when flunarizine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when tetracaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Articaine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when pergolide is combined with nilvadipine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with bromocriptine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when hydromorphone is combined with levodopa.


The risk or severity of adverse effects can be increased when cocaine is combined with etizolam.


The risk or severity of adverse effects can be increased when terconazole is combined with Efonidipine.


The risk or severity of adverse effects can be increased when lidocaine is combined with trimipramine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with alclometasone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when quetiapine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when oxycodone is combined with efavirenz.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with minoxidil.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Paliperidone is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when procyclidine is combined with tubocurarine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Asenapine is combined with zonisamide.


The risk or severity of adverse effects can be increased when ramipril is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when Halobetasol is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when ketamine is combined with clomipramine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with brotizolam.


The risk or severity of adverse effects can be increased when Asenapine is combined with tiagabine.


The risk or severity of adverse effects can be increased when Asenapine is combined with ondansetron.


The risk or severity of adverse effects can be increased when Etidocaine is combined with tetracaine.


The risk or severity of adverse effects can be increased when meprobamate is combined with propofol.


The risk or severity of adverse effects can be increased when anagrelide is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with resveratrol.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when oxymorphone is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when oxymorphone is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when codeine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when tropicamide is combined with tolterodine.


The risk or severity of adverse effects can be increased when nimesulide is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when haloperidol is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when LISURIDE is combined with pilocarpine.


The risk or severity of adverse effects can be increased when cilazapril is combined with resveratrol.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with quetiapine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with moclobemide.


The risk or severity of adverse effects can be increased when nimesulide is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when haloperidol is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when docetaxel is combined with 5-azacytidine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with isoetharine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when cetirizine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when zotepine is combined with butalbital.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Paliperidone.


The risk or severity of adverse effects can be increased when metolazone is combined with captopril.


The risk or severity of adverse effects can be increased when Isoconazole is combined with Clevidipine.


The risk or severity of adverse effects can be increased when procarbazine is combined with tiapride.


The risk or severity of adverse effects can be increased when olanzapine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when salicylamide is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when Articaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when LISURIDE is combined with tacrolimus.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with periciazine.


The risk or severity of adverse effects can be increased when etizolam is combined with clidinium.


The risk or severity of adverse effects can be increased when loxapine is combined with chlordiazepoxide.


The risk or severity of adverse effects can be increased when rapamycin is combined with xylometazoline.


The risk or severity of adverse effects can be increased when fenoldopam is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with carboplatin.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Articaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when proparacaine is combined with primidone.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Apremilast.


The risk or severity of adverse effects can be increased when losartan is combined with Nepafenac.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with desipramine.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when Spirapril is combined with carprofen.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with scopolamine.


The risk or severity of adverse effects can be increased when Asunaprevir is combined with meperidine.


The risk or severity of adverse effects can be increased when rasagiline is combined with isoetharine.


The risk or severity of adverse effects can be increased when Articaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when naratriptan is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when nicardipine is combined with captopril.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with METAXALONE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with nortriptyline.


The risk or severity of adverse effects can be increased when flurazepam is combined with baclofen.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with benazepril.


The risk or severity of adverse effects can be increased when procaine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when mirtazapine is combined with Bambuterol.


The risk or severity of adverse effects can be increased when flurazepam is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when propofol is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when cilazapril is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when proparacaine is combined with butalbital.


The risk or severity of adverse effects can be increased when promazine is combined with dantrolene.


The risk or severity of adverse effects can be increased when nortriptyline is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when flumethasone is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Etomidate is combined with thiopental.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with etizolam.


The risk or severity of adverse effects can be increased when pramipexole is combined with dipyridamole.


The risk or severity of adverse effects can be increased when thioridazine is combined with flurazepam.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with epirizole.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with tolterodine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with flunarizine.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with OXCARBAZEPINE.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when oxazepam is combined with butamben.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with indomethacin.


The risk or severity of adverse effects can be increased when tiapride is combined with cetirizine.


The risk or severity of adverse effects can be increased when dyclonine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Amrinone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when codeine is combined with zaleplon.


The risk or severity of adverse effects can be increased when Pipamperone is combined with efavirenz.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with periciazine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Lomitapide.


The risk or severity of adverse effects can be increased when Olmesartan is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when griseofulvin is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when prazepam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when triamterene is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Etomidate is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Etomidate is combined with Escitalopram.


The risk or severity of adverse effects can be increased when metoclopramide is combined with loxapine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with nicardipine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when minoxidil is combined with acebutolol.


The risk or severity of adverse effects can be increased when loxapine is combined with nitrazepam.


The risk or severity of adverse effects can be increased when DESONIDE is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with butamben.


The risk or severity of adverse effects can be increased when thiothixene is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with methadone.


The risk or severity of adverse effects can be increased when nalbuphine is combined with ethotoin.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with desipramine.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with fleroxacin.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Articaine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with diflunisal.


The risk or severity of adverse effects can be increased when Asenapine is combined with Etomidate.


The risk or severity of adverse effects can be increased when Asenapine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when Asenapine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Normethadone is combined with bumetanide.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when pramipexole is combined with nimodipine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Normethadone is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when carvedilol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when thiamylal is combined with clidinium.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when lidocaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when proparacaine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when procarbazine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when daunorubicin is combined with leflunomide.


The risk or severity of adverse effects can be increased when procarbazine is combined with maprotiline.


The risk or severity of adverse effects can be increased when ramipril is combined with Pregabalin.


The risk or severity of adverse effects can be increased when reserpine is combined with losartan.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with procarbazine.


The risk or severity of adverse effects can be increased when procarbazine is combined with Salmeterol.


The risk or severity of adverse effects can be increased when reserpine is combined with thioridazine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with imipramine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with Aliskiren.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with loratadine.


The risk or severity of adverse effects can be increased when propranolol is combined with penbutolol.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with Amrinone.


The risk or severity of adverse effects can be increased when fludiazepam is combined with clozapine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with METAXALONE.


The risk or severity of adverse effects can be increased when fluocinonide is combined with galanthamine.


The risk or severity of adverse effects can be increased when enflurane is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when fluocinonide is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when sertraline is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with proparacaine.


The risk or severity of adverse effects can be increased when nimodipine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when oxycodone is combined with bupivacaine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Etomidate.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when enalapril is combined with Olsalazine.


The risk or severity of adverse effects can be increased when dibucaine is combined with glutethimide.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when dibucaine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when bromazepam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when bromazepam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when proparacaine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when dibucaine is combined with scopolamine.


The risk or severity of adverse effects can be increased when oxybutynin is combined with topiramate.


The risk or severity of adverse effects can be increased when dipyridamole is combined with Bretylium.


The risk or severity of adverse effects can be increased when doxepin is combined with metaproterenol.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with dicumarol.


The risk or severity of adverse effects can be increased when sevoflurane is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when sevoflurane is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Pipamperone is combined with maprotiline.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when perphenazine is combined with amobarbital.


The risk or severity of adverse effects can be increased when atenolol is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Fospropofol is combined with etizolam.


The risk or severity of adverse effects can be increased when salicylic acid is combined with alclofenac.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with meperidine.


The risk or severity of adverse effects can be increased when Metixene is combined with meperidine.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with nimesulide.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Alvimopan.


The risk or severity of adverse effects can be increased when fludiazepam is combined with felbamate.


The risk or severity of adverse effects can be increased when Asenapine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with clomipramine.


The risk or severity of adverse effects can be increased when butabarbital is combined with ethotoin.


The risk or severity of adverse effects can be increased when modafinil is combined with atorvastatin.


The risk or severity of adverse effects can be increased when loxapine is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Suvorexant.


The risk or severity of adverse effects can be increased when anagrelide is combined with cilostazol.


The risk or severity of adverse effects can be increased when acemetacin is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when acemetacin is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when ramipril is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when quetiapine is combined with glutethimide.


The risk or severity of adverse effects can be increased when perphenazine is combined with zotepine.


The risk or severity of adverse effects can be increased when perphenazine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when fludiazepam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when quetiapine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when nicergoline is combined with Olaparib.


The risk or severity of adverse effects can be increased when Eplerenone is combined with Riociguat.


The risk or severity of adverse effects can be increased when clorazepate is combined with loratadine.


The risk or severity of adverse effects can be increased when miconazole is combined with nimodipine.


The risk or severity of adverse effects can be increased when acemetacin is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when oxprenolol is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when oxprenolol is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when pentazocine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when floctafenine is combined with Mometasone.


The risk or severity of adverse effects can be increased when tretinoin is combined with prazosin.


The risk or severity of adverse effects can be increased when floctafenine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Tavaborole is combined with Clevidipine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when caffeine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with acebutolol.


The risk or severity of adverse effects can be increased when ondansetron is combined with meclizine.


The risk or severity of adverse effects can be increased when brotizolam is combined with zonisamide.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with captopril.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when brotizolam is combined with tiagabine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when Lacidipine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when pentamidine is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with PAMABROM.


The risk or severity of adverse effects can be increased when labetalol is combined with papaverine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Telmisartan.


The risk or severity of adverse effects can be increased when duloxetine is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when diclofenac is combined with fenbufen.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Degarelix.


The risk or severity of adverse effects can be increased when diclofenac is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Iloperidone.


The risk or severity of adverse effects can be increased when baclofen is combined with desipramine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when quinidine is combined with mefloquine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with lithium ion.


The risk or severity of adverse effects can be increased when Rufinamide is combined with amobarbital.


The risk or severity of adverse effects can be increased when valsartan is combined with Masoprocol.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Butethal.


The risk or severity of adverse effects can be increased when clonidine is combined with lisinopril.


The risk or severity of adverse effects can be increased when buspirone is combined with Almotriptan.


The risk or severity of adverse effects can be increased when antipyrine is combined with Clobetasone.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with etizolam.


The risk or severity of adverse effects can be increased when Pramocaine is combined with nefazodone.


The risk or severity of adverse effects can be increased when baclofen is combined with clemastine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Asenapine.


The risk or severity of adverse effects can be increased when brimonidine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with triazolam.


The risk or severity of adverse effects can be increased when Normethadone is combined with clonidine.


The risk or severity of adverse effects can be increased when tretinoin is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when tenoxicam is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with maprotiline.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Salsalate.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with amoxapine.


The risk or severity of adverse effects can be increased when Icatibant is combined with Propacetamol.


The risk or severity of adverse effects can be increased when rapamycin is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when atorvastatin is combined with ketoconazole.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when Tramadol is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with zopiclone.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with mirtazapine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with captopril.


The risk or severity of adverse effects can be increased when carbamazepine is combined with benzocaine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when fosinopril is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when loxapine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when thioridazine is combined with butamben.


The risk or severity of adverse effects can be increased when estazolam is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when pentazocine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when ketamine is combined with enflurane.


The risk or severity of adverse effects can be increased when indapamide is combined with sulpiride.


The risk or severity of adverse effects can be increased when indapamide is combined with digoxin.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Etidocaine.


The risk or severity of adverse effects can be increased when codeine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when desipramine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when amitriptyline is combined with celiprolol.


The risk or severity of adverse effects can be increased when dyclonine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when codeine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when dyclonine is combined with duloxetine.


The risk or severity of adverse effects can be increased when haloprogin is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when Almotriptan is combined with selegiline.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Drospirenone.


The risk or severity of adverse effects can be increased when flunarizine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when methazolamide is combined with nifedipine.


The risk or severity of adverse effects can be increased when pentazocine is combined with midazolam.


The risk or severity of adverse effects can be increased when pentazocine is combined with bromazepam.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Salsalate.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with topiramate.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with Valrubicin.


The risk or severity of adverse effects can be increased when rizatriptan is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when rizatriptan is combined with haloperidol.


The risk or severity of adverse effects can be increased when etizolam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when maprotiline is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when etizolam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when cerulenin is combined with nitrendipine.


The risk or severity of adverse effects can be increased when Limaprost is combined with anagrelide.


The risk or severity of adverse effects can be increased when thiamylal is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Limaprost is combined with dicumarol.


The risk or severity of adverse effects can be increased when Conivaptan is combined with epoprostenol.


The risk or severity of adverse effects can be increased when butabarbital is combined with phenytoin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with metoprolol.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Metixene is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when Flibanserin is combined with duloxetine.


The risk or severity of adverse effects can be increased when reserpine is combined with hydralazine.


The risk or severity of adverse effects can be increased when methazolamide is combined with primidone.


The risk or severity of adverse effects can be increased when primidone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Flibanserin is combined with fluoxetine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with mianserin.


The risk or severity of adverse effects can be increased when methazolamide is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when ramipril is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with glutethimide.


The risk or severity of adverse effects can be increased when captopril is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Propacetamol.


The risk or severity of adverse effects can be increased when captopril is combined with Olsalazine.


The risk or severity of adverse effects can be increased when methadone is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Rufinamide is combined with cocaine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with tiagabine.


The risk or severity of adverse effects can be increased when loxapine is combined with meclizine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with ondansetron.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when butenafine is combined with isradipine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when atorvastatin is combined with DAPTOMYCIN.


The risk or severity of adverse effects can be increased when sulpiride is combined with clemastine.


The risk or severity of adverse effects can be increased when lidocaine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when bifonazole is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when bifonazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when doxazosin is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when glutethimide is combined with HEROIN.


The risk or severity of adverse effects can be increased when bicalutamide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Azelnidipine is combined with fluvastatin.


The risk or severity of adverse effects can be increased when codeine is combined with enflurane.


The risk or severity of adverse effects can be increased when levorphanol is combined with Retigabine.


The risk or severity of adverse effects can be increased when clozapine is combined with losartan.


The risk or severity of adverse effects can be increased when mesalamine is combined with desoximetasone.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when methadone is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Flibanserin.


The risk or severity of adverse effects can be increased when doxazosin is combined with losartan.


The risk or severity of adverse effects can be increased when metolazone is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when midazolam is combined with lidocaine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with digoxin.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with sulpiride.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with secobarbital.


The risk or severity of adverse effects can be increased when cabergoline is combined with imipramine.


The risk or severity of adverse effects can be increased when oxycodone is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Tramadol is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when timolol is combined with methyldopa.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Trifluridine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when nitrazepam is combined with tizanidine.


The risk or severity of adverse effects can be increased when morniflumate is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with potassium chloride.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with maprotiline.


The risk or severity of adverse effects can be increased when tretinoin is combined with indapamide.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with nicotinamide.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with rivastigmine.


The risk or severity of adverse effects can be increased when halcinonide is combined with Demecarium.


The risk or severity of adverse effects can be increased when ramipril is combined with clonidine.


The risk or severity of adverse effects can be increased when Articaine is combined with etizolam.


The risk or severity of adverse effects can be increased when ramipril is combined with fenoprofen.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with scopolamine.


The risk or severity of adverse effects can be increased when ramipril is combined with propranolol.


The risk or severity of adverse effects can be increased when triazolam is combined with flunarizine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when azelastine is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with oxymetholone.


The risk or severity of adverse effects can be increased when Treprostinil is combined with aspirin.


The risk or severity of adverse effects can be increased when Escitalopram is combined with pimozide.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Olopatadine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when thioridazine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when methyldopa is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when thioridazine is combined with gabapentin.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with labetalol.


The risk or severity of adverse effects can be increased when triazolam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when carbamazepine is combined with tetracaine.


The risk or severity of adverse effects can be increased when Metipranolol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with flumethasone.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when enflurane is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when fexofenadine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when brotizolam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when enflurane is combined with bupivacaine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with butalbital.


The risk or severity of adverse effects can be increased when Tolcapone is combined with nortriptyline.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with desoximetasone.


The risk or severity of adverse effects can be increased when proparacaine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when linezolid is combined with Flupentixol.


The risk or severity of adverse effects can be increased when efavirenz is combined with felbamate.


The risk or severity of adverse effects can be increased when reserpine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when benztropine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Fidaxomicin is combined with pravastatin.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with maprotiline.


The risk or severity of adverse effects can be increased when alprazolam is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when celecoxib is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when celecoxib is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when buspirone is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when meprobamate is combined with Lurasidone.


The risk or severity of adverse effects can be increased when thioridazine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when trazodone is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Propiverine is combined with topiramate.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with topiramate.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with clomipramine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Lurasidone.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Halobetasol.


The risk or severity of adverse effects can be increased when Rotigotine is combined with atenolol.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with hydralazine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with cilazapril.


The risk or severity of adverse effects can be increased when dapsone is combined with sulfadiazine.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with ambenonium.


The risk or severity of adverse effects can be increased when eperisone is combined with simvastatin.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with prazosin.


The risk or severity of adverse effects can be increased when Tapentadol is combined with Phenelzine.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with D-mannitol.


The risk or severity of adverse effects can be increased when isradipine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when amobarbital is combined with citalopram.


The risk or severity of adverse effects can be increased when enflurane is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when quetiapine is combined with triprolidine.


The risk or severity of adverse effects can be increased when quetiapine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when quetiapine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when minoxidil is combined with Bretylium.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with vigabatrin.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with butalbital.


The risk or severity of adverse effects can be increased when barnidipine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when thiamylal is combined with Articaine.


The risk or severity of adverse effects can be increased when tolmetin is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when Aclidinium is combined with pentazocine.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Propiverine.


The risk or severity of adverse effects can be increased when Tapentadol is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when thiothixene is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Rufinamide is combined with bupivacaine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with morphine.


The risk or severity of adverse effects can be increased when diazepam is combined with quetiapine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Enasidenib.


The risk or severity of adverse effects can be increased when butamben is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with ethotoin.


The risk or severity of adverse effects can be increased when Melatonin is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when biperiden is combined with orphenadrine.


The risk or severity of adverse effects can be increased when ketamine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when thiopental is combined with METAXALONE.


The risk or severity of adverse effects can be increased when niflumic acid is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when mecamylamine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when perphenazine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when suprofen is combined with triamcinolone.


The risk or severity of adverse effects can be increased when ketorolac is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when captopril is combined with alclofenac.


The risk or severity of adverse effects can be increased when dexamethasone is combined with tubocurarine.


The risk or severity of adverse effects can be increased when Naftifine is combined with Deferasirox.


The risk or severity of adverse effects can be increased when amobarbital is combined with mepivacaine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when pancuronium is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with oxycodone.


The risk or severity of adverse effects can be increased when chloroxine is combined with bepridil.


The risk or severity of adverse effects can be increased when valsartan is combined with dipyridamole.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Olopatadine.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with buspirone.


The risk or severity of adverse effects can be increased when salicylic acid is combined with diltiazem.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Droxicam.


The risk or severity of adverse effects can be increased when Tramadol is combined with zotepine.


The risk or severity of adverse effects can be increased when Tramadol is combined with MELPERONE.


The risk or severity of adverse effects can be increased when meprobamate is combined with fexofenadine.


The risk or severity of adverse effects can be increased when terconazole is combined with nilvadipine.


The risk or severity of adverse effects can be increased when Almotriptan is combined with clomipramine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when dichlorphenamide is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when barnidipine is combined with nimodipine.


The risk or severity of adverse effects can be increased when demeclocycline is combined with Isotretinoin.


The risk or severity of adverse effects can be increased when barnidipine is combined with digoxin.


The risk or severity of adverse effects can be increased when zopiclone is combined with proparacaine.


The risk or severity of adverse effects can be increased when zopiclone is combined with Halazepam.


The risk or severity of adverse effects can be increased when suprofen is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when phentolamine is combined with tretinoin.


The risk or severity of adverse effects can be increased when Naftifine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when propofol is combined with flunarizine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with amoxapine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with benazepril.


The risk or severity of adverse effects can be increased when Vildagliptin is combined with rescinnamine.


The risk or severity of adverse effects can be increased when morphine is combined with tizanidine.


The risk or severity of adverse effects can be increased when nabumetone is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Flupentixol is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when midodrine is combined with oxymetazoline.


The risk or severity of adverse effects can be increased when temazepam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when amifostine is combined with ILOPROST.


The risk or severity of adverse effects can be increased when procaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when antipyrine is combined with Tixocortol.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Vildagliptin is combined with enalapril.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with amisulpride.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Perospirone.


The risk or severity of adverse effects can be increased when sulindac is combined with salicylamide.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Tixocortol is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when imipramine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when brotizolam is combined with tizanidine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with epinephrine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with carvedilol.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with fluocinonide.


The risk or severity of adverse effects can be increased when trazodone is combined with rasagiline.


The risk or severity of adverse effects can be increased when nimodipine is combined with captopril.


The risk or severity of adverse effects can be increased when meperidine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when aminophylline is combined with formoterol.


The risk or severity of adverse effects can be increased when propoxyphene is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Difenoxin.


The risk or severity of adverse effects can be increased when propoxyphene is combined with flunarizine.


The risk or severity of adverse effects can be increased when amisulpride is combined with clidinium.


The risk or severity of adverse effects can be increased when metolazone is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when thiopental is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with amobarbital.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Flibanserin.


The risk or severity of adverse effects can be increased when amisulpride is combined with Normethadone.


The risk or severity of adverse effects can be increased when thiopental is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when cetirizine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Perospirone is combined with butalbital.


The risk or severity of adverse effects can be increased when nicotinic acid is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when Efonidipine is combined with tizanidine.


The risk or severity of adverse effects can be increased when Efonidipine is combined with furosemide.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when oxaprozin is combined with loteprednol.


The risk or severity of adverse effects can be increased when meprobamate is combined with enflurane.


The risk or severity of adverse effects can be increased when tacrolimus is combined with daunorubicin.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Normethadone.


The risk or severity of adverse effects can be increased when lorazepam is combined with fluoxetine.


The risk or severity of adverse effects can be increased when lorazepam is combined with chlordiazepoxide.


The risk or severity of adverse effects can be increased when lorazepam is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when tetracaine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when meperidine is combined with rizatriptan.


The risk or severity of adverse effects can be increased when sevoflurane is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when tubocurarine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when cabergoline is combined with raloxifene.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Droxicam is combined with Tixocortol.


The risk or severity of adverse effects can be increased when tolmetin is combined with etodolac.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when tolmetin is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when tolmetin is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when methocarbamol is combined with Milnacipran.


The risk or severity of adverse effects can be increased when quazepam is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with ketoprofen.


The risk or severity of adverse effects can be increased when Asenapine is combined with procaine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when aspirin is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when Olsalazine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Fospropofol is combined with fexofenadine.


The risk or severity of adverse effects can be increased when zotepine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when zonisamide is combined with clomipramine.


The risk or severity of adverse effects can be increased when dyclonine is combined with prilocaine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when dibucaine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when niflumic acid is combined with loteprednol.


The risk or severity of adverse effects can be increased when Bortezomib is combined with ramipril.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when dibucaine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when timolol is combined with nicardipine.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with Pinaverium.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when pimozide is combined with ethosuximide.


The risk or severity of adverse effects can be increased when triamterene is combined with nadolol.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with pentazocine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with trazodone.


The risk or severity of adverse effects can be increased when pimozide is combined with thiopental.


The risk or severity of adverse effects can be increased when mepivacaine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with diethylstilbestrol.